C07K 7/64
Cyclic peptides containing only normal peptide links
C07K7/64 (Cyclic peptides containing only normal peptide links) appears on 1,118 US grants and 1,573 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,118
- Published applications
- 1,573
- Assignees
- 709
- Inventors
- 3,295
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 10 | 0 |
| 1996 | 6 | 0 |
| 1997 | 16 | 0 |
| 1998 | 18 | 0 |
| 1999 | 28 | 0 |
| 2000 | 19 | 0 |
| 2001 | 21 | 5 |
| 2002 | 16 | 19 |
| 2003 | 26 | 41 |
| 2004 | 21 | 28 |
| 2005 | 14 | 29 |
| 2006 | 24 | 35 |
| 2007 | 19 | 31 |
| 2008 | 23 | 16 |
| 2009 | 14 | 36 |
| 2010 | 24 | 42 |
| 2011 | 16 | 46 |
| 2012 | 16 | 50 |
| 2013 | 39 | 77 |
| 2014 | 70 | 102 |
| 2015 | 54 | 82 |
| 2016 | 69 | 90 |
| 2017 | 59 | 79 |
| 2018 | 58 | 80 |
| 2019 | 57 | 84 |
| 2020 | 63 | 91 |
| 2021 | 46 | 84 |
| 2022 | 48 | 89 |
| 2023 | 38 | 76 |
| 2024 | 59 | 95 |
| 2025 | 43 | 87 |
| 2026 | 38 | 79 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- VIPR2 antagonist peptide6 Oct 2026US 12,753,206 B2Ichimaru Pharcos Co., Ltd.
- Compositions for delivery of antisense compounds22 Sep 2026US 12,741,989 B2Entrada Therapeutics, Inc.
- Peptide compound targeting elastin-derived peptides and use thereof15 Sep 2026US 12,735,454 B2Shenzhen Turier Biotech Co. Ltd.
- Methods and compositions for chimeric antigen receptor targeting cancer cells1 Sep 2026US 12,721,892 B2The University of North Carolina at Chapel Hill
- Multicyclic peptides and methods for their preparation1 Sep 2026US 12,723,059 B2Universiteit Van Amsterdam
- New ternatin-type cyclopeptides for use in therapy8 Oct 2026US 2026/0308205 A1
- Cyclized bioactive peptides for controlling insects1 Oct 2026US 2026/0293892 A1
- Cyclic peptides as pet imaging agents of granzyme b1 Oct 2026US 2026/0297134 A1Merck Sharp & Dohme Corp.
- Rippled beta-sheets from mixed chirality linear and cyclic peptides24 Sep 2026US 2026/0285904 A1
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases24 Sep 2026US 2026/0285908 A1Protagonist Therapeutics, Inc.
Most cited
By later US patents
- Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis162US 5,811,515 ACalifornia Institute of Technology · 1998
- Regulated apoptosis125US 5,834,266 APresident and Fellows of Harvard College · 1998
- Regulated transcription of targeted genes and other biological events125US 5,869,337 ABoard of Trustees of Leland S. Stanford, Jr. University · 1999
- Cyclosporin analogues and their pharmaceutical uses125US 7,511,013 B2AMR Technology, Inc. · 2009
- Stabilized alpha helical peptides and uses thereof119US 7,723,469 B2Dana-Farber Cancer Institute, Inc. · 2010